Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gross

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Nature Communications|January 27, 2011
Efficient quantum state tomographyMarcus Cramer, Martin B Plenio, Steven T Flammia, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentationRudolf Arnold, Yuan-Jia Chen, Frederico Costa, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomasUlrich-Frank Pape, Aurel Perren, Bruno Niederle, et al.
Neuroendocrinology|October 10, 2019
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, et al.
Neuroendocrinology|February 22, 2007
Gastrinoma (duodenal and pancreatic)Robert T Jensen, Bruno Niederle, Emmanuel Mitry, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
Neuroendocrinology|May 21, 2010
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumorsBeata Kos-Kudła, Dermot O'Toole, Massimo Falconi, et al.
Leukemia Research|August 2, 2011
A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseAmir T Fathi, Omotayo Arowojolu, Ian Swinnen, et al.
Neuroendocrinology|October 16, 2007
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinomaUrsula Plöckinger, Anne Couvelard, Massimo Falconi, et al.
Nature Communications|May 31, 2018
Induction of anergic or regulatory tumor-specific CD4<sup>+</sup> T cells in the tumor-draining lymph nodeRuby Alonso, Héloïse Flament, Sébastien Lemoine, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Nature Communications|January 27, 2011
Efficient quantum state tomographyMarcus Cramer, Martin B Plenio, Steven T Flammia, et al.
Neuroendocrinology|August 29, 2009
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentationRudolf Arnold, Yuan-Jia Chen, Frederico Costa, et al.
Neuroendocrinology|January 21, 2012
ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomasUlrich-Frank Pape, Aurel Perren, Bruno Niederle, et al.
Neuroendocrinology|October 10, 2019
Authors' Response to the Letter by Lamarca et al. Entitled "Temozolomide-Capecitabine Chemotherapy for Neuroendocrine Neoplasms: The Dilemma of Treatment Duration" Regarding "Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms"Eleftherios Chatzellis, Kosmas Daskalakis, Anna Angelousi, et al.
Neuroendocrinology|February 22, 2007
Gastrinoma (duodenal and pancreatic)Robert T Jensen, Bruno Niederle, Emmanuel Mitry, et al.
Neuroendocrinology|June 6, 2019
Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine NeoplasmsEleftherios Chatzellis, Anna Angelousi, Kosmas Daskalakis, et al.
Neuroendocrinology|May 21, 2010
ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumorsBeata Kos-Kudła, Dermot O'Toole, Massimo Falconi, et al.
Leukemia Research|August 2, 2011
A potential therapeutic target for FLT3-ITD AML: PIM1 kinaseAmir T Fathi, Omotayo Arowojolu, Ian Swinnen, et al.
Neuroendocrinology|October 16, 2007
Consensus guidelines for the management of patients with digestive neuroendocrine tumours: well-differentiated tumour/carcinoma of the appendix and goblet cell carcinomaUrsula Plöckinger, Anne Couvelard, Massimo Falconi, et al.
Nature Communications|May 31, 2018
Induction of anergic or regulatory tumor-specific CD4<sup>+</sup> T cells in the tumor-draining lymph nodeRuby Alonso, Héloïse Flament, Sébastien Lemoine, et al.
Pageof 5